AHI Viewpoint
AHI Statement on Guidance for Industry #152
(August 6, 2027) The Food and Drug Administration’s Center for Veterinary Medicine (CVM) today issued updated Guidance for Industry #152 which outlines the qualitative risk assessment companies should follow when seeking approval for antimicrobial products used in food producing animals. The document updates previous guidance and revises the classification of antimicrobial compounds according to their […]
AHI Veterinarian Comments on New World Screwworm & Pet Health
The current risk of New World Screwworm to most pets remains low, but awareness and early action are important. “Pet owners in areas with recorded outbreaks are encouraged to regularly check pets for cuts, bites, or other wounds,” said Ellen Hart, DVM, vice president of regulatory and international affairs at the Animal Health Institute (AHI). […]
AHI Board Elects Officers, Executive Committee
(Washington, DC–July 23, 2026) The Animal Health Institute’s Board of Directors this week elected Jamie Brannan of Zoetis as Board Chair and Brad McCollum of Ceva as Vice-Chair for the 2026-28 term. Brannan is Executive Vice President and Chief Commercial Officer at Zoetis, and McCollum is Senior Vice President, North America, at Ceva. Joseph N. […]
AHI Statement on New World Screwworm Response
(Washington, DC – June 16, 2026) Following the confirmed detection of New World Screwworm (NWS) in the United States, the Animal Health Institute (AHI) today emphasized the animal health industry’s commitment to helping veterinarians, animal owners, farmers, ranchers, and public officials respond to this serious pest. The current risk to animals, humans, and the food […]















